ResearcherEugene Applebaum College of Pharmacy and Health SciencesNo recent work listed
Arun K. Iyer
Matched on ORCID iD 0000-0002-4428-0222; OpenAlex author ID A5045993993. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 5
2015: 3 papers · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper
Papers 4
- Nanomedicine for overcoming therapeutic and diagnostic challenges associated with pancreatic cancer. Last author DOI 10.1016/j.drudis.2022.02.026↗
- Parenterally administrable nano-micelles of 3,4-difluorobenzylidene curcumin for treating pancreatic cancer. Last author DOI 10.1016/j.colsurfb.2015.05.007↗
- Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells. Last author DOI 10.1016/j.colsurfb.2015.09.043↗
- Hyaluronic Acid Engineered Nanomicelles Loaded with 3,4-Difluorobenzylidene Curcumin for Targeted Killing of CD44+ Stem-Like Pancreatic Cancer Cells. Last author DOI 10.1021/acs.biomac.5b00941↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Disha Iyengar · 1 shared paper, 2022 · strength 0.20
- Sanjeev Banerjee · 3 shared papers, 2015 · strength 0.19
- Paper Parenterally administrable nano-micelles of 3,4-difluorobenzylidene curcumin for treating pancreatic cancer. DOI 10.1016/j.colsurfb.2015.05.007↗
- Paper Hyaluronic Acid Engineered Nanomicelles Loaded with 3,4-Difluorobenzylidene Curcumin for Targeted Killing of CD44+ Stem… DOI 10.1021/acs.biomac.5b00941↗
- Paper Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 … DOI 10.1016/j.colsurfb.2015.09.043↗
- Subhash Padhyé · 3 shared papers, 2015 · strength 0.19
- Paper Parenterally administrable nano-micelles of 3,4-difluorobenzylidene curcumin for treating pancreatic cancer. DOI 10.1016/j.colsurfb.2015.05.007↗
- Paper Hyaluronic Acid Engineered Nanomicelles Loaded with 3,4-Difluorobenzylidene Curcumin for Targeted Killing of CD44+ Stem… DOI 10.1021/acs.biomac.5b00941↗
- Paper Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 … DOI 10.1016/j.colsurfb.2015.09.043↗
- Prashant Kesharwani · 3 shared papers, 2015 · strength 0.19
- Paper Parenterally administrable nano-micelles of 3,4-difluorobenzylidene curcumin for treating pancreatic cancer. DOI 10.1016/j.colsurfb.2015.05.007↗
- Paper Hyaluronic Acid Engineered Nanomicelles Loaded with 3,4-Difluorobenzylidene Curcumin for Targeted Killing of CD44+ Stem… DOI 10.1021/acs.biomac.5b00941↗
- Paper Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 … DOI 10.1016/j.colsurfb.2015.09.043↗
- Fazlul H. Sarkar · 3 shared papers, 2015 · strength 0.19
- Paper Parenterally administrable nano-micelles of 3,4-difluorobenzylidene curcumin for treating pancreatic cancer. DOI 10.1016/j.colsurfb.2015.05.007↗
- Paper Hyaluronic Acid Engineered Nanomicelles Loaded with 3,4-Difluorobenzylidene Curcumin for Targeted Killing of CD44+ Stem… DOI 10.1021/acs.biomac.5b00941↗
- Paper Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 … DOI 10.1016/j.colsurfb.2015.09.043↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.